Altered amygdala subregion-related circuits in treatment-naïve post-traumatic stress disorder comorbid with major

Minlan Yuan1, Spiro P Pantazatos2, Hongru Zhu3

  • 1Mental Health Center and Psychiatric Laboratory, the State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, China; Huaxi Brain Research Center, West China Hospital of Sichuan University, Chengdu, China; Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, NY, United States; Department of Psychiatry, Columbia University, New York, NY, United States.

Related Concept Videos

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Here we outline the procedure for MRI-guided repetitive transcranial magnetic stimulation to the dorsomedial prefrontal cortex as an experimental treatment for major depressive...
14.5K
Post-traumatic Stress Disorder01:27

Post-traumatic Stress Disorder

Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
488
Deep Transcranial Magnetic Stimulation to Alleviate Symptoms of Post-Traumatic Stress Disorder03:15

Deep Transcranial Magnetic Stimulation to Alleviate Symptoms of Post-Traumatic Stress Disorder

Source: Tendler, A., et al. How to Use the H1 Deep Transcranial Magnetic Stimulation Coil for Conditions Other than Depression. J. Vis. Exp. (2017)This video demonstrates the use of deep transcranial magnetic stimulation (dTMS) to alleviate symptoms of post-traumatic stress disorder, or PTSD. It begins by identifying reduced activity in the medial prefrontal cortex (mPFC) as a key factor contributing to the overactivation of the amygdala and heightened fear responses. By applying targeted...
289
Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder05:19

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Deep brain stimulation triggered by a patient-specific neural biomarker of a high-symptom state may better control symptoms of major depressive disorder compared to continuous, open-loop stimulation. This protocol provides a workflow for identifying a patient-specific neural biomarker and controlling the delivery of therapeutic stimulation based on the identified biomarker.
3.3K
Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Here, we present a protocol that investigates the relationship between cognitive symptoms and sleep quality in patients with major depressive disorder. The THINC-integrated tool and polysomnography were used to evaluate cognitive symptoms and sleep...
1.2K
An Introduction to Modeling Behavioral Disorders and Stress10:17

An Introduction to Modeling Behavioral Disorders and Stress

Recently, it has been discovered that behavioral conditions such as, depression, anxiety and stress-response have a neurological basis. Understanding the biological underpinnings of these conditions may help scientists in developing more effective therapies to treat these disorders. Typically, rodent models are used in this field and behavioral scientists create these models using interventions like drug administration or surgery. It is important to understand how to create and evaluate rodent...
19.6K